Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population

Human Genetics

Volumn 124, Issue 1, 2008, Pages 63-71

  Leak, Tennille S ^a   Mychaleckyj, Josyf C ^a,b,c   Smith, Shelly G ^a   Keene, Keith L ^a   Gordon, Candace J ^a   Hicks, Pamela J ^a   Freedman, Barry I ^a   Bowden, Donald W ^a   Sale, Michèle M ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; ESTROGEN RECEPTOR ALPHA; GENE PRODUCT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 11; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PARKIN; PARKIN 2; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE LIKE 4 PROTEIN; PROTEIN ESR1; RGS PROTEIN; RGS17 PROTEIN; SOMATOMEDIN B RECEPTOR; SPACER DNA; T COMPLEX 1 PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE 1;

ADDITION LINE; ADULT; AFRICAN AMERICAN; ALLELISM; ANCESTRY INFORMATIVE MARKER; ARTICLE; CHROMOSOME 6Q; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOMINANT INHERITANCE; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 46949109487     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-008-0523-7     Document Type: Article

References (37)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
2. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A (2001) High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98:581-584
3. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120
4. Carter JS, Pugh JA, Monterrosa A (1996) Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125:221-232
5. Craig RL, Chu WS, Elbein SC (2007) Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab 90:338-344
6. Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP (2001) A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet 68:1149-1164
7. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations: A review and computer program. Control Clin Trials 11:116-128
8. Elbein SC, Wang X, Karim MA, Chu WS, Silver KD (2006) Analysis of coding variants in the betacellulin gene in type 2 diabetes and insulin secretion in African American subjects. BMC Med Genet 7:62
9. Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, Abraira C (2005) Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care 28:1954-1958
10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
11. Gallagher CJ, Gordon CJ, Langefeld CD, Mychaleckyj JC, Freedman BI, Rich SS, Bowden DW, Sale MM (2006) Association of the μ-opioid receptor gene with type 2 diabetes mellitus in an African American population. Mol Genet Metab 87:54-60
12. Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, Gordon CJ, Freedman BI, Rich SS, Bowden DW, Sale MM (2007a) Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes 56:675-684
13. Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychalecky JC, Bryer-Ash M, Rich SS, Bowden DW, Sale MM (2007b) Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: The insulin resistance atherosclerosis family study. Diabetes 56:2135-2141
14. Green LE, Lange EM, Langefeld CD (2001) Power comparisons of phase-known versus phase-unknown haplotype analyses for case-control designs. Am J Hum Genet 69:1948a
15. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J (2007) Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30:842-847
16. Juretic D, Krajnovic V, Lukac-Bajalo J (2002) Altered distribution of urinary glycosaminoglycans in diabetic subjects. Acta Diabetol 39:123-128
17. Karim MA, Wang X, Hale TC, Elbein SC (2005) Insulin promoter factor 1 variation is associated with type 2 diabetes in African Americans. BMC Med Genet 6:37
18. Karim MA, Craig RL, Wang X, Hale TC, Elbein SC (2006) Analysis of FOXO1A as a candidate gene for type 2 diabetes. Mol Genet Metab 88:171-177
19. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
20. Kobayashi M, Sugumaran G, Liu J, Shworak NW, Silbert JE, Rosenberg RD (1999) Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan/chondroitin sulfate. J Biol Chem 274:10474-10480
21. Lin HY, Wang CL, Hsiao PJ, Lu YC, Chen SY, Lin KD, Hsin SC, Hsieh MC, Shin SJ (2007) SUMO4 M55 V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes 56:1177-1180
22. Lindsay RS, Kobes S, Knowler WC, Bennett PH, Hanson RL (2001) Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of type 2 diabetes and BMI in Pima Indians. Diabetes 50:2850-2857
23. Lopez-Avalos MD, Duvivier-Kali VF, Xu G, Bonner-Weir S, Sharma A, Weir GC (2006) Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes 55:1223-1231
24. National Institute of Diabetes and Digestive and Kidney Diseases (2005) National diabetes statistics fact sheet: General information and national estimates on diabetes in the United States. U.S. Department of Health and Human Services, National Institute of Health, Bethesda
25. Noso S, Fujisawa T, Kawabata Y, Asano K, Hiromine Y, Fukai A, Ogihara T, Ikegami H (2007) Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population. J Clin Endocrinol Metab 92:2358-2362
26. Pugh JA, Medina RA, Cornell JC, Basu S (1995) NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes 44:1375-1380
27. Rodriguez-Munoz M, Bermudez D, Sanchez-Blazquez P, Garzon J (2007) Sumoylated RGS-Rz proteins act as scaffolds for Mu-opioid receptors and G-protein complexes in mouse brain. Neuropsychopharmacology 32:842-850
28. Sale MM, Freedman BI, Langefeld CD, Williams AH, Hicks PJ, Colicigno CJ, Beck SR, Brown WM, Rich SS, Bowden DW (2004) A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes 53:830-837
29. Sale MM, Smith SG, Mychaleckyj JC, Keene KL, Langefeld CD, Leak TS, Hicks PJ, Bowden DW, Rich SS, Freedman BI (2007) Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 56:2638-2642
30. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Bostrom K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Rastam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjogren M, Sterner M, Surti A, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336
31. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu T, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Saramies J, Buchanan TA, Watanabe RM, Valle TT, Kinnunen L, Abecasis GR, Pugh EW, Doheny KF, Bergman RN, Tuomilehto J, Collins FS, Boehnke M (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345
32. Shimizu N, Asakawa S, Minoshima S, Kitada T, Hattori N, Matsumine H, Yokochi M, Yamamura Y, Mizuno Y (2000) PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism. J Neural Transm Suppl 58:19-30
33. Silver K, Shetty A (2002) IPF-1 gene variation and the development of type 2 diabetes. Mol Genet Metab 75:287-289
34. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
35. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5:649-658
36. Tang H, Peng J, Wang P, Risch NJ (2005) Estimation of individual admixture: Analytical and study design considerations. Genet Epidemiol 28:289-301
37. Westfall PH, Young SS (1993) Resampling-based multiple testing: Examples and methods for P value adjustment. Wiley, New York